Pharmaids Pharmaceuticals Limited (BOM:524572)
India · Delayed Price · Currency is INR 30.09
-0.12 (-0.40%)
At close: Sep 10, 2026
Pharmaids Pharmaceuticals Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | - | 1.34 | 8.23 | 48.04 | 127.54 | 4.07 |
Short-Term Investments | - | - | - | - | 33.05 | - |
Cash & Short-Term Investments | 1.34 | 1.34 | 8.23 | 48.04 | 160.59 | 4.07 |
Cash Growth | -93.77% | -83.78% | -82.87% | -70.09% | 3841.48% | 103.44% |
Accounts Receivable | - | 44.91 | 31.28 | 26.79 | 20.54 | 13.39 |
Other Receivables | - | 26.3 | - | - | - | - |
Receivables | - | 71.2 | 31.28 | 26.79 | 20.54 | 13.39 |
Inventory | - | 9.98 | 124.37 | 36.06 | - | 8.88 |
Prepaid Expenses | - | 2.25 | 4.02 | 1.57 | - | - |
Other Current Assets | - | 25.14 | 41.95 | 22.87 | 2.02 | 0.34 |
Total Current Assets | - | 109.91 | 209.86 | 135.32 | 183.16 | 26.68 |
Property, Plant & Equipment | - | 286.18 | 491.8 | 384.59 | 21.06 | 4.81 |
Long-Term Investments | - | 17.26 | 13.22 | - | - | - |
Goodwill | - | 314.17 | 314.17 | 314.17 | - | - |
Other Intangible Assets | - | - | 5.45 | 5.45 | - | - |
Long-Term Accounts Receivable | - | - | - | - | - | 14.16 |
Long-Term Deferred Tax Assets | - | 122.78 | 105.03 | 66.68 | 27.08 | 3.56 |
Long-Term Deferred Charges | - | - | - | - | 1.21 | - |
Other Long-Term Assets | - | 22.32 | 59 | 7.21 | 0.85 | 61.92 |
Total Assets | - | 872.62 | 1,199 | 913.41 | 245.85 | 111.12 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | - | 27.8 | 163.21 | 51.18 | 18.83 | 23.06 |
Accrued Expenses | - | 75.87 | 40.35 | 22.75 | 0.28 | - |
Short-Term Debt | - | 74.44 | 40.57 | 11.53 | - | - |
Current Portion of Long-Term Debt | - | 29.8 | 18.58 | 10.14 | - | - |
Current Portion of Leases | - | 6.42 | 7.93 | 7.13 | - | - |
Current Income Taxes Payable | - | - | 0.26 | - | - | - |
Other Current Liabilities | - | 25.75 | 16.25 | 13.03 | 2.14 | 1.35 |
Total Current Liabilities | - | 240.09 | 287.15 | 115.76 | 21.25 | 24.41 |
Long-Term Debt | - | 136.44 | 323.84 | 61.85 | - | - |
Long-Term Leases | - | 18.27 | 29.35 | 24.68 | - | - |
Pension & Post-Retirement Benefits | - | 1.79 | 7.78 | 6.15 | - | - |
Other Long-Term Liabilities | - | - | -0 | - | -0 | - |
Total Liabilities | - | 396.6 | 648.11 | 208.44 | 21.25 | 24.41 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | - | 352.68 | 352.68 | 352.68 | 214.44 | 102.69 |
Additional Paid-In Capital | - | 505.75 | 505.75 | 505.75 | 104.24 | - |
Retained Earnings | - | -383.94 | -266.77 | -139.3 | -98.89 | -23.33 |
Comprehensive Income & Other | - | 2.05 | 1.55 | 1.34 | 4.81 | 7.36 |
Total Common Equity | 476.54 | 476.54 | 593.2 | 720.47 | 224.6 | 86.72 |
Minority Interest | - | -0.51 | -42.79 | -15.5 | - | - |
Shareholders' Equity | 476.03 | 476.03 | 550.42 | 704.97 | 224.6 | 86.72 |
Total Liabilities & Equity | - | 872.62 | 1,199 | 913.41 | 245.85 | 111.12 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 233.82 | 265.38 | 420.27 | 115.33 | - | - |
Net Cash (Debt) | -232.49 | -264.05 | -412.04 | -67.29 | 160.59 | 4.07 |
Net Cash Growth | - | - | - | - | 3841.48% | 103.44% |
Net Cash Per Share | -11.70 | -7.49 | -11.68 | -2.96 | 12.45 | 0.40 |
Filing Date Shares Outstanding | 35 | 35.27 | 35.27 | 35.27 | 21.49 | 10.31 |
Total Common Shares Outstanding | 35 | 35.27 | 35.27 | 35.27 | 21.49 | 10.31 |
Working Capital | - | -130.18 | -77.29 | 19.56 | 161.91 | 2.27 |
Book Value Per Share | 13.43 | 13.51 | 16.82 | 20.43 | 10.45 | 8.41 |
Tangible Book Value | 162.37 | 162.37 | 273.59 | 400.85 | 224.6 | 86.72 |
Tangible Book Value Per Share | 4.58 | 4.60 | 7.76 | 11.37 | 10.45 | 8.41 |
Land | - | 76.16 | 254.5 | 178.22 | - | - |
Buildings | - | 20.15 | 27.87 | 11.85 | - | - |
Machinery | - | 141.44 | 164.33 | 111.11 | - | 5.09 |
Construction In Progress | - | 60.95 | 45.3 | 70.01 | - | 4.5 |